TIMP1, reported to be a multi-faceted biomarker in CRC, can function as a diagnostic biomarker for CRC and is linked to the immunological microenvironment, drug sensitivity, and inhibition of ferroptosis (40). Here, TIMP1 is linked to colorectal carcinoma.